Tenax Therapeutics (TENX) Long-Term Deferred Tax (2015 - 2020)

Tenax Therapeutics (TENX) has 6 years of Long-Term Deferred Tax data on file, last reported at $347.0 in Q4 2020.

• For the quarter ending Q4 2020, Long-Term Deferred Tax fell 100.0% year-over-year to $347.0; the trailing twelve-month figure through Dec 2020 stood at $347.0 (down 100.0% YoY), and the FY2020 full-year result was $347.0, down 100.0% from the prior year.
• Long-Term Deferred Tax fell to $347.0 in Q4 2020, from $34.9 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $34.9 million in Q4 2019 to a low of $347.0 in Q4 2020.
• A 5-year average of $20.1 million and a median of $32.2 million in 2017 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax jumped 57286.56% in 2017 and tumbled 100.0% in 2020, its largest moves.
• Tracing TENX's Long-Term Deferred Tax over 5 years: stood at $56180.0 in 2016, then jumped by 57286.56% to $32.2 million in 2017, then advanced by 3.24% to $33.3 million in 2018, then grew by 4.96% to $34.9 million in 2019, then plunged by 100.0% to $347.0 in 2020.
• Business Quant data shows TENX's Long-Term Deferred Tax at $347.0 in Q4 2020, $34.9 million in Q4 2019, and $33.3 million in Q4 2018.